Impax Asset Management Group
BIO icon

Impax Asset Management Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Impax Asset Management Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,845
Closed -$661K – 373
2023
Q3 		$661K Sell
1,845
-34
-2% -$13.1K ﹤0.01% 305
2023
Q2 		$712K Buy
1,879
+800
+74% +$326K ﹤0.01% 304
2023
Q1 		$517K Hold
1,079
– – ﹤0.01% 329
2022
Q4 		$454K Sell
1,079
-43
-4% -$17.4K ﹤0.01% 327
2022
Q3 		$468K Sell
1,122
-46
-4% -$22.9K ﹤0.01% 327
2022
Q2 		$578K Hold
1,168
– – ﹤0.01% 313
2022
Q1 		$658K Sell
1,168
-6
-0.5% -$3.62K ﹤0.01% 323
2021
Q4 		$887K Sell
1,174
-32
-3% -$23.9K ﹤0.01% 299
2021
Q3 		$900K Hold
1,206
– – ﹤0.01% 293
2021
Q2 		$777K Hold
1,206
– – ﹤0.01% 308
2021
Q1 		$689K Buy
+1,206
New +$714K ﹤0.01% 317

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return